Market Research Logo

Nephrology and Urology Devices Market Analysis Report By Type (Dialysis, Benign Prostatic Hyperplasia, Endoscopy, Urinary Stone, Urinary Incontinence & Pelvic Organ Prolapse), And Segment Forecasts, 2018 - 2024

Nephrology and Urology Devices Market Analysis Report By Type (Dialysis, Benign Prostatic Hyperplasia, Endoscopy, Urinary Stone, Urinary Incontinence & Pelvic Organ Prolapse), And Segment Forecasts, 2018 - 2024

The global nephrology and urology devices market size is expected to reach USD 31.3 billion by 2024, according to a new report by Grand View Research, Inc., exhibiting a 7.1% CAGR during the forecast period. Increasing prevalence of chronic kidney diseases is expected to fuel market growth.

This high prevalence of diseases can be attributed to unhealthy lifestyle habits of people around the world. Moreover, growing geriatric population, who are more prone to hypertension, obesity, diabetes, urinary disorders, and other kidney chronic conditions, is expected to fuel demand for nephrology and urology devices.

Advancements in device technology, such as inclusion of prosthetics in urology, percutaneous methods for stone disintegration and extraction, and extracorporeal shockwave lithotripsy, are anticipated to boost the market over the forecast period. Furthermore, presence of highly advanced pipeline products such as bioartificial kidney is presumed to present the market with lucrative growth opportunities in future.

Increase in demand for minimally invasive techniques is also likely to propel the market in the coming years. Nephrology and urology devices facilitate early diagnosis and shorter treatment duration in most surgical procedures. Minimal pain, heightened cost efficiency, safety, efficacy, rapid recovery, and reduced hospital stay are other benefits offered by these devices. This is expected to boost adoption over the forecast period.

Further key findings from the report suggest:

  • The global urology segment is anticipated to reach USD 21.4 billion by 2024, at a CAGR of 6.9% from 2016 to 2024
  • By type, the benign prostatic hyperplasia segment is anticipated to witness lucrative growth over the forecast period
  • Europe held the dominant revenue share as of 2015 owing to a large target population. Growth across this region is primarily driven by presence of prominent market players implementing extensive expansion strategies such as product development and mergers and acquisitions
  • Asia Pacific, especially countries such as India and China, is expected to observe remarkable growth in the coming years
  • The global industry is dominated by few players and is marked by extensive new product development and high-end investments in R&D. Level of competition is expected to remain high over the forecast period
  • Some of the key players in the market are Baxter International, Inc.; Fresenius Medical Care AG & Co. KGaA; Boston Scientific; and C.R. Bard Inc.


Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
1.3. List of Data Sources
Chapter 2. Executive Summary
Chapter 3. Market Snapshot
Chapter 4. Market Variables, Trends & Scope
4.1. Market segmentation & scope
4.2. Market Driver Analysis
4.3. Market Restraint Analysis
4.4. Penetration & growth prospect mapping
4.5. Nephrology and urology Competitive Landscape, 2015
4.5.1. Company market share analysis
4.5.2. Competitive landscape: market position analysis
4.6. Nephrology and urology devices-SWOT Analysis, By Factor (political & legal, economic and technological)
4.7. Industry Analysis - Porter's
Chapter 5. Market Categorization 1: Type Estimates & Trend Analysis
5.1. Nephrology and urology devices Market: Type movement analysis
5.2. Dialysis
5.2.1. Dialysis market estimates and forecasts, 2013 - 2024 (USD Billion)
5.3. Urinary Stone
5.3.1. Urinary stone market estimates and forecasts, 2013 - 2024 (USD Billion)
5.3.2. Ureteral Stents
5.3.2.1. Ureteral stents market estimates and forecasts, 2013 - 2024 (USD Billion)
5.3.3. Lithotripters
5.3.3.1. Lithotripters market estimates and forecasts, 2013 - 2024 (USD Billion)
5.4. Urinary Incontinence & Pelvic Organ Prolapse
5.4.1. Urinary incontinence & pelvic organ prolapse market estimates and forecasts, 2013 - 2024 (USD Billion)
5.4.2. Sacral Neuromodulation
5.4.2.1. Sacral neuromodulation market estimates and forecasts, 2013 - 2024 (USD Billion)
5.4.3. Vaginal Meshes & Slings
5.4.3.1. Vaginal meshes & slings market estimates and forecasts, 2013 - 2024 (USD Billion)
5.4.4. Urethral Inserts & Pessaries
5.4.4.1. Urethral inserts & pessaries market estimates and forecasts, 2013 - 2024 (USD Billion)
5.5. Benign Prostatic Hyperplasia
5.5.1. Benign prostatic hyperplasia market estimates and forecasts, 2013 - 2024 (USD Billion)
5.5.2. Catheter Ablation
5.5.2.1. Catheter ablation market estimates and forecasts, 2013 - 2024 (USD Billion)
5.5.3. Prostatic Stents
5.5.3.1. Prostatic stents market estimates and forecasts, 2013 - 2024 (USD Billion)
5.5.4. Endoscopy
5.5.4.1. Endoscopy market estimates and forecasts, 2013 - 2024 (USD Billion)
5.5.5. Others
5.5.5.1. Others market estimates and forecasts, 2013 - 2024 (USD Billion)
Chapter 6. Market Categorization 2: Regional Estimates & Trend Analysis, By Type
6.1. Nephrology and urology devices market shares by region, 2015 & 2024
6.2. North America
6.2.1. North America market estimates and forecasts, by type, 2013 - 2024 (USD Billion)
6.2.1.1. U.S. market estimates and forecasts
6.2.1.2. Canada market estimates and forecasts
6.3. Europe
6.3.1. Europe market estimates and forecasts, by type, 2013 - 2024 (USD Billion)
6.3.1.1. UK market estimates and forecasts
6.3.1.2. Germany market estimates and forecasts
6.4. Asia Pacific
6.4.1. Asia Pacific market estimates and forecasts, by type, 2013 - 2024 (USD Billion)
6.4.1.1. Japan market estimates and forecasts
6.4.1.2. China market estimates and forecasts
6.4.1.3. India market estimates and forecasts
6.5. Latin America
6.5.1. Latin America market estimates and forecasts, by type, 2013 - 2024 (USD Billion)
6.5.1.1. Brazil market estimates and forecasts
6.5.1.2. Mexico market estimates and forecasts
6.6. MEA
6.6.1. MEA market estimates and forecasts, by type, 2013 - 2024 (USD Billion)
6.6.1.1. South Africa market estimates and forecasts
Chapter 7. Competitive Landscape
7.1. Strategy framework
7.2. Market participation categorization
7.3. Company Profiles
7.3.1. Asahi Kasei Corporation
7.3.1.1. Company overview
7.3.1.2. Financial performance
7.3.1.3. Product benchmarking
7.3.1.4. Strategic initiatives
7.3.2. B.Braun Group
7.3.2.1. Company overview
7.3.2.2. Financial performance
7.3.2.3. Product benchmarking
7.3.2.4. Strategic initiatives
7.3.3. Baxter International, Inc
7.3.3.1. Company overview
7.3.3.2. Financial performance
7.3.3.3. Product benchmarking
7.3.3.4. Strategic initiatives
7.3.4. Boston Scientific Corporation
7.3.4.1. Company overview
7.3.4.2. Financial performance
7.3.4.3. Product benchmarking
7.3.4.4. Strategic initiatives
7.3.5. C.R. Bard, Inc
7.3.5.1. Company overview
7.3.5.2. Financial performance
7.3.5.3. Product benchmarking
7.3.5.4. Strategic initiatives
7.3.6. Coloplast AS
7.3.6.1. Company overview
7.3.6.2. Financial performance
7.3.6.3. Product benchmarking
7.3.6.4. Strategic initiatives
7.3.7. Cook Medical
7.3.7.1. Company overview
7.3.7.2. Financial performance
7.3.7.3. Product benchmarking
7.3.7.4. Strategic initiatives
7.3.8. Dornier MedTech
7.3.8.1. Company overview
7.3.8.2. Financial performance
7.3.8.3. Product benchmarking
7.3.8.4. Strategic initiatives
7.3.9. Fresenius Medical Care AG & Co. KGaA
7.3.9.1. Company overview
7.3.9.2. Financial performance
7.3.9.3. Product benchmarking
7.3.9.4. Strategic initiatives
7.3.10. Nikkiso Co.Ltd.
7.3.10.1. Company overview
7.3.10.2. Financial performance
7.3.10.3. Product benchmarking
7.3.10.4. Strategic initiatives
7.3.11. Nipro Corporation
7.3.11.1. Company overview
7.3.11.2. Financial performance
7.3.11.3. Product benchmarking
7.3.11.4. Strategic initiatives
7.3.12. NxStage Medical, Inc.
7.3.12.1. Company overview
7.3.12.2. Financial performance
7.3.12.3. Product benchmarking
7.3.12.4. Strategic initiatives
7.3.13. Olympus Medical Systems
7.3.13.1. Company overview
7.3.13.2. Financial performance
7.3.13.3. Product benchmarking
7.3.13.4. Strategic initiatives
7.3.14. Rockwell Medical Technologies, Inc.
7.3.14.1. Company overview
7.3.14.2. Financial performance
7.3.14.3. Product benchmarking
7.3.14.4. Strategic initiatives
7.3.15. Terumo Corporation
7.3.15.1. Company overview
7.3.15.2. Financial performance
7.3.15.3. Product benchmarking
7.3.15.4. Strategic initiatives
7.3.16. Svenska Cellulosa Aktiebolaget (SCA)
7.3.16.1. Company overview
7.3.16.2. Financial performance
7.3.16.3. Product benchmarking
7.3.16.4. Strategic initiatives
7.3.17. ONTEX International N.V.
7.3.17.1. Company overview
7.3.17.2. Financial performance
7.3.17.3. Product benchmarking
7.3.17.4. Strategic initiatives
7.3.18. Kimberly-Clark Corporation
7.3.18.1. Company overview
7.3.18.2. Financial performance
7.3.18.3. Product benchmarking
7.3.18.4. Strategic initiatives
7.3.19. First Quality Enterprises, Inc.
7.3.19.1. Company overview
7.3.19.2. Financial performance
7.3.19.3. Product benchmarking
7.3.19.4. Strategic initiatives
7.3.20. Teleflex Incorporated
7.3.20.1. Company overview
7.3.20.2. Financial performance
7.3.20.3. Product benchmarking
7.3.20.4. Strategic initiatives
7.3.21. Siemens Healthineers
7.3.21.1. Company overview
7.3.21.2. Financial performance
7.3.21.3. Product benchmarking
7.3.21.4. Strategic initiatives
7.3.22. Medtronic
7.3.22.1. Company overview
7.3.22.2. Financial performance
7.3.22.3. Product benchmarking
7.3.22.4. Strategic initiatives
7.3.23. Medline Industries, Inc.
7.3.23.1. Company overview
7.3.23.2. Financial performance
7.3.23.3. Product benchmarking
7.3.23.4. Strategic initiatives
7.3.24. STORZ Medical AG
7.3.24.1. Company overview
7.3.24.2. Financial performance
7.3.24.3. Product benchmarking
7.3.24.4. Strategic initiatives
List of Tables
TABLE 1 Country share estimation
TABLE 2 North America nephrology and urology devices market, by type, 2013 - 2024 (USD Billion)
TABLE 3 North America urinary stone devices market, by type, 2013 - 2024 (USD Billion)
TABLE 4 North America urinary incontinence & pelvic organ prolapse devices market, by type, 2013 - 2024 (USD Billion)
TABLE 5 North America benign prostatic hyperplasia devices market, by type, 2013 - 2024 (USD Billion)
TABLE 6 U.S. nephrology and urology devices market, by type, 2013 - 2024 (USD Billion)
TABLE 7 U.S. urinary stone devices market, by type, 2013 - 2024 (USD Billion)
TABLE 8 U.S. urinary incontinence & pelvic organ prolapse devices market, by type, 2013 - 2024 (USD Billion)
TABLE 9 Canada nephrology and urology devices market, by type, 2013 - 2024 (USD Billion)
TABLE 10 Canada urinary stone devices market, by type, 2013 - 2024 (USD Billion)
TABLE 11 Canada urinary incontinence & pelvic organ prolapse devices market, by type, 2013 - 2024 (USD Billion)
TABLE 12 Europe nephrology and urology devices market, by type, 2013 - 2024 (USD Billion)
TABLE 13 Europe urinary stone devices market, by type, 2013 - 2024 (USD Billion)
TABLE 14 Europe urinary incontinence & pelvic organ prolapse devices market, by type, 2013 - 2024 (USD Billion)
TABLE 15 Germany nephrology and urology devices market, by type, 2013 - 2024 (USD Billion)
TABLE 16 Germany urinary stone devices market, by type, 2013 - 2024 (USD Billion)
TABLE 17 Germany urinary incontinence & pelvic organ prolapse devices market, by type, 2013 - 2024 (USD Billion)
TABLE 18 UK nephrology and urology devices market, by type, 2013 - 2024 (USD Billion)
TABLE 19 UK urinary stone devices market, by type, 2013 - 2024 (USD Billion)
TABLE 20 UK urinary incontinence & pelvic organ prolapse devices market, by type, 2013 - 2024 (USD Billion)
TABLE 21 Asia Pacific nephrology and urology devices market, by type, 2013 - 2024 (USD Billion)
TABLE 22 Asia Pacific urinary stone devices market, by type, 2013 - 2024 (USD Billion)
TABLE 23 Asia Pacific urinary incontinence & pelvic organ prolapse devices market, by type, 2013 - 2024 (USD Billion)
TABLE 24 Japan nephrology and urology devices market, by type, 2013 - 2024 (USD Billion)
TABLE 25 Japan urinary stone devices market, by type, 2013 - 2024 (USD Billion)
TABLE 26 Japan urinary incontinence & pelvic organ prolapse devices market, by type, 2013 - 2024 (USD Billion)
TABLE 27 China nephrology and urology devices market, by type, 2013 - 2024 (USD Billion)
TABLE 28 China urinary stone devices market, by type, 2013 - 2024 (USD Billion)
TABLE 29 China urinary incontinence & pelvic organ prolapse devices market, by type, 2013 - 2024 (USD Billion)
TABLE 30 India nephrology and urology devices market, by type, 2013 - 2024 (USD Billion)
TABLE 31 India urinary stone devices market, by type, 2013 - 2024 (USD Billion)
TABLE 32 India urinary incontinence & pelvic organ prolapse devices market, by type, 2013 - 2024 (USD Billion)
TABLE 33 Latin America nephrology and urology devices market, by type, 2013 - 2024 (USD Billion)
TABLE 34 Latin America urinary stone devices market, by type, 2013 - 2024 (USD Billion)
TABLE 35 Latin America urinary incontinence & pelvic organ prolapse devices market, by type, 2013 - 2024 (USD Billion)
TABLE 36 Brazil nephrology and urology devices market, by type, 2013 - 2024 (USD Billion)
TABLE 37 Brazil urinary stone devices market, by type, 2013 - 2024 (USD Billion)
TABLE 38 Brazil urinary incontinence & pelvic organ prolapse devices market, by type, 2013 - 2024 (USD Billion)
TABLE 39 Mexico nephrology and urology devices market, by type, 2013 - 2024 (USD Billion)
TABLE 40 Mexico urinary stone devices market, by type, 2013 - 2024 (USD Billion)
TABLE 41 Mexico urinary incontinence & pelvic organ prolapse devices market, by type, 2013 - 2024 (USD Billion)
TABLE 42 MEA nephrology and urology devices market, by type, 2013 - 2024 (USD Billion)
TABLE 43 MEA urinary stone devices market, by type, 2013 - 2024 (USD Billion)
TABLE 44 MEA urinary incontinence & pelvic organ prolapse devices market, by type, 2013 - 2024 (USD Billion)
TABLE 45 South Africa nephrology and urology devices market, by type, 2013 - 2024 (USD Billion)
TABLE 46 South Africa urinary stone devices market, by type, 2013 - 2024 (USD Billion)
TABLE 47 South Africa urinary incontinence & pelvic organ prolapse devices market, by type, 2013 - 2024 (USD Billion)
List of Figures
FIG. 1 Market summary (USD Billion)
FIG. 2 Market trends & outlook
FIG. 3 Market segmentation & scope
FIG. 4 Market driver relevance analysis (Current & future impact)
FIG. 5 Market restraint relevance analysis (Current & future impact)
FIG. 6 Penetration & growth prospect mapping
FIG. 7 Nephrology and urology company market share, 2015
FIG. 8 Competitive Landscape Analysis, 2015
FIG. 9 SWOT Analysis, By Factor (political & legal, economic and technological)
FIG. 10 Porter’s Five Forces Analysis
FIG. 11 Nephrology and urology devices market type outlook key takeaways
FIG. 12 Nephrology and urology devices market: Type movement analysis
FIG. 13 Global dialysis market, 2013 - 2024 (USD Billion)
FIG. 14 Global urinary stone market, 2013 - 2024 (USD Billion)
FIG. 15 Global urinary stents market, 2013 - 2024 (USD Billion)
FIG. 16 Global lithotripters market, 2013 - 2024 (USD Billion)
FIG. 17 Global urinary incontinence & pelvic organ prolapse market, 2013 - 2024 (USD Billion)
FIG. 18 Global sacral neuromodulation market, 2013 - 2024 (USD Billion)
FIG. 19 Global vaginal meshes & slings market, 2013 - 2024 (USD Billion)
FIG. 20 Global urethral inserts & pessaries market, 2013 - 2024 (USD Billion)
FIG. 21 Global benign prostatic hyperplasia market, 2013 - 2024 (USD Billion)
FIG. 22 Global catheter ablation market, 2013 - 2024 (USD Billion)
FIG. 23 Global prostatic stents market, 2013 - 2024 (USD Billion)
FIG. 24 Global endoscopy market, 2013 - 2024 (USD Billion)
FIG. 25 Global others market, 2013 - 2024 (USD Billion)
FIG. 26 Regional market place: Key takeaways
FIG. 27 Regional outlook, 2015 & 2024
FIG. 28 North America nephrology and urology devices market, 2013 - 2024 (USD Billion)
FIG. 29 U.S. nephrology and urology devices market, 2013 - 2024 (USD Billion)
FIG. 30 Canada nephrology and urology devices market, 2013 - 2024 (USD Billion)
FIG. 31 Europe nephrology and urology devices market, 2013 - 2024 (USD Billion)
FIG. 32 Germany nephrology and urology devices market, 2013 - 2024 (USD Billion)
FIG. 33 UK nephrology and urology devices market, 2013 - 2024 (USD Billion)
FIG. 34 Asia Pacific nephrology and urology devices market, 2013 - 2024 (USD Billion)
FIG. 35 Japan nephrology and urology devices market, 2013 - 2024 (USD Billion)
FIG. 36 China nephrology and urology devices market, 2013 - 2024 (USD Billion)
FIG. 37 India nephrology and urology devices market, 2013 - 2024 (USD Billion)
FIG. 38 Latin America nephrology and urology devices market, 2013 - 2024 (USD Billion)
FIG. 39 Brazil nephrology and urology devices market, 2013 - 2024 (USD Billion)
FIG. 40 Mexico nephrology and urology devices market, 2013 - 2024 (USD Billion)
FIG. 41 MEA nephrology and urology devices market, 2013 - 2024 (USD Billion)
FIG. 42 South Africa nephrology and urology devices market, 2013 - 2024 (USD Billion)
FIG. 43 Strategy framework
FIG. 44 Participant categorization

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report